Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Germin-like protein Cit s 1 is a glycoprotein allergen isolated from sweet orange (Citrus sinensis). It belongs to the germin-like subfamily within the cupin superfamily of plant proteins. Cit s 1 is identified as a 24 kDa glycoprotein that binds specific IgE in more than 60% of orange-allergic individuals, although only a small subset have positive clinical responses (such as skin reactions) when exposed to purified Cit s 1. Its IgE-binding is heavily dependent on complex N-glycan structures, which can result in false positive diagnosis of orange allergy if based solely on in vitro IgE testing. Cit s 1 does not currently serve as a therapeutic target; its primary significance is as a component allergen in food allergy diagnosis and research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Germin-like protein (Citrus sinensis) (Cit s 1).